Latest Insider Transactions at Zymeworks Inc. (ZYME)
This section provides a real-time view of insider transactions for Zymeworks Inc. (ZYME). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Zymeworks Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Zymeworks Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2020
|
Kathryn O'Driscoll Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,920
+50.0%
|
$99,280
$34.24 P/Share
|
|
Nov 02
2020
|
Ali Tehrani Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
3,500
-5.85%
|
$136,500
$39.04 P/Share
|
|
Jan 31
2019
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
250,000
-7.94%
|
$4,000,000
$16.0 P/Share
|
|
Nov 06
2018
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
700,000
-18.19%
|
$9,800,000
$14.0 P/Share
|
|
Sep 24
2018
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,027
-0.05%
|
$32,432
$16.36 P/Share
|
|
Sep 18
2018
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
6,870
-0.18%
|
$96,180
$14.56 P/Share
|
|
Sep 17
2018
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
6,865
-0.18%
|
$96,110
$14.58 P/Share
|
|
Sep 14
2018
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,009
-0.23%
|
$126,126
$14.58 P/Share
|
|
Sep 13
2018
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,900
-0.54%
|
$292,600
$14.32 P/Share
|
|
Sep 12
2018
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,059
-0.26%
|
$140,826
$14.83 P/Share
|
|
Sep 11
2018
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
11,277
-0.29%
|
$157,878
$14.87 P/Share
|
|
Sep 10
2018
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,500
-0.11%
|
$63,000
$14.44 P/Share
|
|
Aug 31
2018
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
700
-0.02%
|
$9,800
$14.26 P/Share
|
|
Aug 30
2018
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,440
-0.09%
|
$48,160
$14.35 P/Share
|
|
Aug 29
2018
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,312
-0.06%
|
$32,368
$14.26 P/Share
|
|
Aug 14
2018
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,000
-0.08%
|
$42,000
$14.28 P/Share
|
|
Aug 13
2018
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,531
-0.12%
|
$63,434
$14.33 P/Share
|
|
Aug 10
2018
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,898
-0.05%
|
$26,572
$14.28 P/Share
|
|
Aug 03
2018
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,650
-0.04%
|
$21,450
$13.55 P/Share
|
|
Aug 02
2018
|
Lilly & CO Eli > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
19,400
-0.49%
|
$252,200
$13.31 P/Share
|